1. Home
  2. LSTA vs CPIX Comparison

LSTA vs CPIX Comparison

Compare LSTA & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • CPIX
  • Stock Information
  • Founded
  • LSTA 1980
  • CPIX 1999
  • Country
  • LSTA United States
  • CPIX United States
  • Employees
  • LSTA N/A
  • CPIX N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • CPIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LSTA Health Care
  • CPIX Health Care
  • Exchange
  • LSTA Nasdaq
  • CPIX Nasdaq
  • Market Cap
  • LSTA 31.2M
  • CPIX 68.7M
  • IPO Year
  • LSTA N/A
  • CPIX 2009
  • Fundamental
  • Price
  • LSTA $2.52
  • CPIX $5.20
  • Analyst Decision
  • LSTA Strong Buy
  • CPIX
  • Analyst Count
  • LSTA 1
  • CPIX 0
  • Target Price
  • LSTA $15.00
  • CPIX N/A
  • AVG Volume (30 Days)
  • LSTA 62.8K
  • CPIX 4.2M
  • Earning Date
  • LSTA 02-27-2025
  • CPIX 03-04-2025
  • Dividend Yield
  • LSTA N/A
  • CPIX N/A
  • EPS Growth
  • LSTA N/A
  • CPIX N/A
  • EPS
  • LSTA N/A
  • CPIX N/A
  • Revenue
  • LSTA N/A
  • CPIX $36,785,442.00
  • Revenue This Year
  • LSTA N/A
  • CPIX N/A
  • Revenue Next Year
  • LSTA N/A
  • CPIX N/A
  • P/E Ratio
  • LSTA N/A
  • CPIX N/A
  • Revenue Growth
  • LSTA N/A
  • CPIX N/A
  • 52 Week Low
  • LSTA $2.19
  • CPIX $1.04
  • 52 Week High
  • LSTA $4.20
  • CPIX $6.43
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 39.52
  • CPIX 73.26
  • Support Level
  • LSTA $2.47
  • CPIX $4.12
  • Resistance Level
  • LSTA $2.74
  • CPIX $6.43
  • Average True Range (ATR)
  • LSTA 0.22
  • CPIX 0.67
  • MACD
  • LSTA -0.02
  • CPIX 0.23
  • Stochastic Oscillator
  • LSTA 21.82
  • CPIX 71.72

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: